FIGS, Inc. filings document the company’s healthcare apparel business, operating results and public-company governance. Form 8-K reports furnish earnings releases and Regulation FD presentations covering net revenues, scrubwear and non-scrubwear categories, U.S. and international sales, active customer measures, average order value, gross margin, operating expenses and outlook disclosures.
The company’s proxy materials address board matters, executive compensation, equity awards and annual meeting governance. Other current reports disclose material agreements, including office lease arrangements related to corporate facilities. Together, FIGS’ regulatory filings describe the business economics, capital and compensation structures, governance practices and material events of a direct-to-consumer healthcare apparel issuer.
FIGS, Inc. received a Form 144 notice for a planned sale of 23,356 Class A common shares, with an aggregate market value of $172,528.61. The filing lists E*TRADE Financial Corporation as broker and the NYSE as the exchange, with an approximate sale date of 11/04/2025.
The shares to be sold relate to equity that was acquired on 11/03/2025 upon vesting of 59,241 restricted stock units under the issuer’s 2021 Equity Incentive Award Plan, noted as consideration for “Services Rendered.” Shares outstanding were 154,989,563.
FIGS, Inc. CFO Sarah Oughtred reported the vesting and settlement of restricted stock units that increased her beneficial holdings and the sale of a portion of shares to cover taxes. On 10/03/2025 she sold 9,968 shares of Class A common stock at $7.36 per share under a 10b5-1 instruction letter to satisfy tax and fee obligations tied to RSU vesting. After the transactions she beneficially owned 868,090 shares, of which 773,554 are RSUs representing contingent rights to receive Class A shares. The Form 4 was signed by an attorney-in-fact on 10/06/2025.
Catherine Spear, CEO and director of FIGS, Inc. (FIGS), reported the vesting and settlement of restricted stock units and an associated sell-to-cover tax sale on 10/02/2025. The filing shows 62,213 Class A shares sold at $6.8809 per share solely to satisfy tax and fee obligations under a 10b5-1 plan. After the transactions, the reporting person beneficially owns 1,907,033 Class A shares directly and indirectly, plus 5,469,161 Class B shares convertible into Class A, and 19,347,466 Class A shares underlying vested options. The report discloses that 1,339,906 of the owned securities are RSUs that vested and settled.
FIGS, Inc. insider Sarah Oughtred filed a Form 144 disclosing a proposed sale of 9,968 shares of Class A common stock with an aggregate market value of $73,364.48, expected on 10/03/2025 on the NYSE. The shares were acquired on 10/01/2025 upon vesting of Restricted Stock Units under the company's 2021 Equity Incentive Award Plan; the filing records 20,067 shares acquired in that vesting event and notes payment as services rendered.
The filing also lists a prior sale by the same person on 08/04/2025 of 99,834 shares for gross proceeds of $617,972.46. The filer certifies they are not aware of undisclosed material adverse information about the issuer. This notice is a routine compliance disclosure under Rule 144 describing recent acquisitions and proposed dispositions by an insider.
Catherine Spear reports beneficial ownership of 26,290,834 shares of FIGS Class A common stock, representing 14.6% of the Class A outstanding based on 154,989,563 shares as of July 31, 2025. Effective August 12, 2025, Spear had 727,097 fully vested options repriced from $22.00 to $6.63 per share, with vesting schedules extended but no change to expiration dates or share counts. Spear holds 508,356 Class A shares and 1,352,608 Class B shares (convertible 1:1), 120,980 restricted stock units, and options to purchase 19,395,123 Class A shares vested/exercisable within 60 days. On August 13, 2025, she sold 65,866 shares at $6.88 to cover taxes and fees. The filing notes certain trust-held shares and a Voting Agreement among Voting Parties, while disclaiming beneficial ownership of other parties' shares.
FIGS, Inc. reporting person Heather L. Hasson beneficially owns 14,802,602 shares of Class A common stock, representing 8.7% of the outstanding Class A shares based on 154,989,563 shares outstanding. The filing discloses that Hasson directly holds 350,329 Class A shares and 1,072,846 Class B shares (convertible one-for-one), and holds options to purchase 11,629,314 Class A shares exercisable within 60 days. Certain fully vested options totaling 3,590,925 shares were repriced to an exercise price of $6.63 per share and had their vesting schedules extended, without changing expiration dates or underlying share counts. The filing also notes limited shared ownership interests held through trusts and an LLC.
FIGS insider transaction summary: Catherine Spear, the company's CEO, director and a 10% owner, reported on Form 4 that 65,866 shares of Class A Common Stock were sold on August 13, 2025 at $6.88 per share solely to cover taxes and fees arising from RSU vesting pursuant to a 10b5-1 instruction. Following that sale, Ms. Spear beneficially owned 1,969,246 shares of Class A Common Stock directly and indirectly, plus significant additional holdings not reported on this Form 4, including 5,469,161 Class B shares convertible into Class A and 18,958,606 shares underlying vested options.
Separately, on August 12, 2025 the company completed a one-time option repricing affecting 727,097 fully vested options originally granted May 26, 2021: the exercise price was reduced from $22.00 to $6.63, and the repriced options now vest in 24 equal monthly installments beginning September 12, 2025; expiration dates and share counts remain unchanged.
FIGS, Inc. insider Heather L. Hasson reported multiple equity transactions on August 12, 2025. The filing shows 947,868 RSUs were acquired with $0 price and 1,298,197 shares of Class A common stock reported as beneficially owned following the RSU grant. The reporting person also holds 2,814,480 Class B shares convertible into Class A and 11,449,396 Class A shares underlying vested options (not reported on this Form 4). The filing discloses a one-time option repricing effective August 12, 2025 that reduced exercise prices for two previously granted, fully vested option pools: 727,097 options from $22.00 to $6.63 and 2,863,828 options from $11.79 to $6.63, with vesting schedules extended and no change to expiration dates or option counts. Some shares are held indirectly through a trust and Hollywood Capital Partners LLC.
FIGS, Inc. Schedule 13G/A discloses material institutional holdings in the company's Class A common stock. Ameriprise Financial, Inc. and affiliated Ameriprise Entities report beneficial ownership of 13,936,468 shares, representing 9.0% of the class, with essentially all holdings recorded as shared voting and dispositive power. A group of Threadneedle/TAM entities each report 13,313,175 shares (8.6%) and the CT (Lux) American Smaller Companies sub-fund reports 8,532,198 shares (5.5%), with the Fund showing sole voting power for its position.
The filing states AFI, as parent, may be deemed to beneficially own shares reported by its subsidiaries while those subsidiaries disclaim beneficial ownership. The certifying language affirms these holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
FIGS filed a Form 144 notice reporting a proposed sale of 65,866 shares of Class A common stock on the NYSE through E*TRADE, with an aggregate market value of $453,158.08. The filing lists total outstanding shares of 154,989,563 and an approximate sale date of 08/13/2025.
The shares were acquired on 08/12/2025 upon vesting of 128,082 restricted stock units awarded under the company's 2021 Equity Incentive Award Plan; the consideration is recorded as services rendered. The form reports no securities sold in the past three months. Certain filer contact fields and the identity of the person for whose account the sale is proposed are not specified in the visible content.